Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Assets (2016 - 2025)

Historic Assets for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to $2.3 billion.

  • Conmed's Assets rose 84.56% to $2.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.3 billion, marking a year-over-year increase of 84.56%. This contributed to the annual value of $2.3 billion for FY2025, which is 84.56% up from last year.
  • Latest data reveals that Conmed reported Assets of $2.3 billion as of Q4 2025, which was up 84.56% from $2.3 billion recorded in Q3 2025.
  • In the past 5 years, Conmed's Assets registered a high of $2.3 billion during Q2 2025, and its lowest value of $1.7 billion during Q1 2021.
  • In the last 5 years, Conmed's Assets had a median value of $2.3 billion in 2023 and averaged $2.2 billion.
  • Per our database at Business Quant, Conmed's Assets surged by 3066.84% in 2022 and then tumbled by 159.75% in 2024.
  • Conmed's Assets (Quarter) stood at $1.8 billion in 2021, then skyrocketed by 30.1% to $2.3 billion in 2022, then rose by 0.11% to $2.3 billion in 2023, then rose by 0.27% to $2.3 billion in 2024, then grew by 0.85% to $2.3 billion in 2025.
  • Its Assets stands at $2.3 billion for Q4 2025, versus $2.3 billion for Q3 2025 and $2.3 billion for Q2 2025.